Mutations in transmembrane domains 1, 4 and 9 of the Plasmodium falciparum chloroquine resistance transporter alter susceptibility to chloroquine, quinine and quinidine

Molecular Microbiology

Volumn 63, Issue 1, 2007, Pages 270-282

  Cooper, Roland A ^a   Lane, Kristin D ^a   Deng, Bingbing ^b   Mu, Jianbing ^c   Patel, Jigar J ^b   Wellems, Thomas E ^c   Su, Xinzhuan ^c   Ferdig, Michael T ^b  

^a OLD DOMINION UNIVERSITY   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISIN; CHLOROQUINE; MEMBRANE PROTEIN; PLASMODIUM FALCIPARUM CHLOROQUINE RESISTANCE TRANSPORTER PROTEIN; PROTOZOAL PROTEIN; QUINIDINE; QUININE; VERAPAMIL;

AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; CLONE; CONTROLLED STUDY; DRUG SELECTIVITY; NONHUMAN; PLASMODIUM FALCIPARUM; POINT MUTATION; PRIORITY JOURNAL; PROTEIN DOMAIN; QUANTITATIVE ANALYSIS; STEREOSPECIFICITY;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE; MEMBRANE PROTEINS; MEMBRANE TRANSPORT PROTEINS; MUTATION; PLASMODIUM FALCIPARUM; PROTOZOAN PROTEINS; QUINIDINE; QUININE;

PLASMODIUM FALCIPARUM;

EID: 33845711820     PISSN: 0950382X     EISSN: 13652958     Source Type: Journal    
DOI: 10.1111/j.1365-2958.2006.05511.x     Document Type: Article

References (62)

1. Arai, M., Mitsuke, H., Ikeda, M., Xia, J.X., Kikuchi, T., Satake, M., and Shimizu, T. (2004) ConPred II: a consensus prediction method for obtaining transmembrane topology models with high reliability. Nucleic Acids Res 32: 390-393.
2. Arunlakshana, O., and Schild, H.O. (1959) Some quantitative uses of drug antagonists. Br J Pharmacol Chemother 14: 48-58.
3. Baird, J.K. (2005) Effectiveness of antimalarial drugs. N Engl J Med 352: 1565-1577.
4. Berenbaum, M.C. (1978) A method for testing for synergy with any number of agents. J Infect Dis 137: 122-130.
5. Bray, P.G., Mungthin, M., Ridley, R.G., and Ward, S.A. (1998) Access to hematin: the basis of chloroquine resistance. Mol Pharmacol 54: 170-179.
6. Bray, P.G., Martin, R.E., Tilley, L., Ward, S.A., Kirk, K., and Fidock, D.A. (2005) Defining the role of PfCRT in Plasmodium falciparum chloroquine resistance. Mol Microbiol 56: 323-333.
7. Bray, P.G., Mungthin, M., Hastings, I.M., Biagini, G.A., Saidu, D.K., Lakshmanan, V., et al. (2006) PfCRT and the transvacuolar proton electrochemical gradient: regulating the access of chloroquine to ferriprotoporphyrin IX. Mol Microbiol 62: 238-251.
8. Chou, A.C., and Fitch, C.D. (1980) Hemolysis of mouse erythrocytes by ferriprotoporphyrin IX and chloroquine. Chemotherapeutic implications. J Clin Invest 66: 856-858.
9. Cooper, R.A., Ferdig, M.T., Su, X.Z., Ursos, L.M., Mu, J., Nomura, T., et al. (2002) Alternative mutations at position 76 of the vacuolar transmembrane protein PfCRT are associated with chloroquine resistance and unique stereospecific quinine and quinidine responses in Plasmodium falciparum. Mol Pharmacol 61: 35-42.
10. Cooper, R.A., Hartwig, C.L., and Ferdig, M.T. (2005) pfcrt is more than the Plasmodium falciparum chloroquine resistance gene: a functional and evolutionary perspective. Acta Trop 94: 170-180.
11. Desjardins, R.E., Canfield, C.J., Haynes, J.D., and Chulay, J.D. (1979) Quantitative assessment of antimalarial activity in vitro by a semiautomated microdilution technique. Antimicrob Agents Chemother 16: 710-718.
12. Djimde, A., Doumbo, O.K., Cortese, J.F., Kayentao, K., Doumbo, S., Diourte, Y., et al. (2001) A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 344: 257-263.
13. Dorn, A., Vippagunta, S.R., Matile, H., Jaquet, C., Vennerstrom, J.L., and Ridley, R.G. (1998) An assessment of drug-haematin binding as a mechanism for inhibition of haematin polymerisation by quinoline antimalarials. Biochem Pharmacol 55: 727-736.
14. Duraisingh, M.T., and Cowman, A.F. (2005) Contribution of the pfmdr1 gene to antimalarial drug-resistance. Acta Trop 94: 181-190.
15. Durrand, V., Berry, A., Sem, R., Glaziou, P., Beaudou, J., and Fandeur, T. (2004) Variations in the sequence and expression of the Plasmodium falciparum chloroquine resistance transporter (PfCRT) and their relationship to chloroquine resistance in vitro. Mol Biochem Parasitol 136: 273-285.
16. Ferdig, M.T., Cooper, R.A., Mu, J., Deng, B., Joy, D.A., Su, X.Z., and Wellems, T.E. (2004) Dissecting the loci of low-level quinine resistance in malaria parasites. Mol Microbiol 52: 985-997.
17. Fidock, D.A., Nomura, T., Talley, A.K., Cooper, R.A., Dzekunov, S.M., Ferdig, M.T., et al. (2000) Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6: 861-871.
18. Fitch, C.D. (2004) Ferriprotoporphyrin IX, phospholipids, and the antimalarial actions of quinoline drugs. Life Sci 74: 1957-1972.
19. Gassis, S., and Rathod, P.K. (1996) Frequency of drug resistance in Plasmodium falciparum: a nonsynergistic combination of 5-fluoroorotate and atovaquone suppresses in vitro resistance. Antimicrob Agents Chemother 40: 914-919.
20. Goldberg, D.E., Slater, A.F., Cerami, A., and Henderson, G.B. (1990) Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc Natl Acad Sci USA 87: 2931-2935.
21. Hall, A.P. (1973) Letter: quinine and chloroquine antagonism in falciparum malaria. Trans R Soc Trop Med Hyg 67: 425.
22. Hooiveld, G.J., Heegsma, J., van Montfoort, J.E., Jansen, P.L., Meijer, D.K., and Muller, M. (2002) Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins. Br J Pharmacol 135: 1685-1694.
23. Huaman, M.C., Yoshinaga, K., Suryanatha, A., Suarsana, N., and Kanbara, H. (2004) Short report: polymorphisms in the chloroquine resistance transporter gene in Plasmodium falciparum isolates from Lombok, Indonesia. Am J Trop Med Hyg 71: 40-42.
24. Johnson, D.J., Fidock, D.A., Mungthin, M., Lakshmanan, V., Sidhu, A.B., Bray, P.G., and Ward, S.A. (2004) Evidence for a central role for PfCRT in conferring Plasmodium falciparum resistance to diverse antimalarial agents. Mol Cell 15: 867-877.
25. Karle, J.M., and Bhattacharjee, A.K. (1999) Stereoelectronic features of the cinchona alkaloids determine their differential antimalarial activity. Bioorg Med Chem 7: 1769-1774.
26. Krogstad, D.J., Gluzman, I.Y., Kyle, D.E., Oduola, A.M., Martin, S.K., Milhous, W.K., and Schlesinger, P.H. (1987) Efflux of chloroquine from Plasmodium falciparum: mechanism of chloroquine resistance. Science 238: 1283-1285.
27. Krogstad, D.J., Gluzman, I.Y., Herwaldt, B.L., Schlesinger, P.H., and Wellems, T.E. (1992) Energy dependence of chloroquine accumulation and chloroquine efflux in Plasmodium falciparum. Biochem Pharmacol 43: 57-62.
28. Kyle, D.E., Oduola, A.M., Martin, S.K., and Milhous, W.K. (1990) Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro. Trans R Soc Trop Med Hyg 84: 474-478.
29. Kyte, J., and Doolittle, R.F. (1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105-132.
30. Laduron, P.M. (1988) Stereospecificity in binding studies. A useful criterion though insufficient to prove the presence of receptors. Biochem Pharmacol 37: 37-40.
31. Lakshmanan, V., Bray, P.G., Verdier-Pinard, D., Johnson, D.J., Horrocks, P., Muhle, R.A., et al. (2005) A critical role for PfCRT K76T in Plasmodium falciparum verapamil-reversible chloroquine resistance. EMBO J 24: 2294-2305.
32. Lambros, C., and Vanderberg, J.P. (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65: 418-420.
33. Martin, R.E., and Kirk, K. (2004) The malaria parasite's chloroquine resistance transporter is a member of the drug/metabolite transporter superfamily. Mol Biol Evol 21: 1938-1949.
34. Mu, J., Ferdig, M.T., Feng, X., Joy, D.A., Duan, J., Furuya, T., et al. (2003) Multiple transporters associated with malaria parasite responses to chloroquine and quinine. Mol Microbiol 49: 977-989.
35. +-ATPase of Streptococcus pneumoniae. J Bacteriol 178: 2455-2458.
36. Naude, B., Brzostowski, J.A., Kimmel, A.R., and Wellems, T.E. (2005) Dictyostelium discoideum expresses a malaria chloroquine resistance mechanism upon transfection with mutant, but not wild-type, Plasmodium falciparum transporter PfCRT. J Biol Chem 280: 25596-25603.
37. Notterman, D.A., Drayer, D.E., Metakis, L., and Reidenberg, M.M. (1986) Stereoselective renal tubular secretion of quinidine and quinine. Clin Pharmacol Ther 40: 511-517.
38. Pagola, S., Stephens, P.W., Bohle, D.S., Kosar, A.D., and Madsen, S.K. (2000) The structure of malaria pigment beta-haematin. Nature 404: 307-310.
39. Rathod, P.K., McErlean, T., and Lee, P.C. (1997) Variations in frequencies of drug resistance in Plasmodium falciparum. Proc Natl Acad Sci USA 94: 9389-9393.
40. Rohrbach, P., Sanchez, C.P., Hayton, K., Friedrich, O., Patel, J., Sidhu, A.B., et al. (2006) Genetic linkage of pfmdr1 with food vacuolar solute import in Plasmodium falciparum. EMBO J 25: 3000-3011.
41. Rosario, V. (1981) Cloning of naturally occurring mixed infections of malaria parasites. Science 212: 1037-1038.
42. Saliba, K.J., Folb, P.I., and Smith, P.J. (1998) Role for the Plasmodium falciparum digestive vacuole in chloroquine resistance. Biochem Pharmacol 56: 313-320.
43. Sanchez, C.P., McLean, J.E., Stein, W., and Lanzer, M. (2004) Evidence for a substrate specific and inhibitable drug efflux system in chloroquine resistant Plasmodium falciparum strains. Biochemistry 43: 16365-16373.
44. Sanchez, C.P., McLean, J.E., Rohrbach, P., Fidock, D.A., Stein, W.D., and Lanzer, M. (2005) Evidence for a pfcrt-associated chloroquine efflux system in the human malarial parasite Plasmodium falciparum. Biochemistry 44: 9862-9870.
45. Sheldon, R.S., Rahmberg, M., and Duff, H.J. (1990) Quinidine/quinine: stereospecific electrophysiologic and antiarrhythmic effects in a canine model of ventricular tachycardia. J Cardiovasc Pharmacol 16: 818-823.
46. Sidhu, A.B., Verdier-Pinard, D., and Fidock, D.A. (2002) Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298: 210-213.
47. Sidhu, A.B., Valderramos, S.G., and Fidock, D.A. (2005) pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol 57: 913-926.
48. Stahel, E., Druilhe, P., and Gentilini, M. (1988) Antagonism of chloroquine with other antimalarials. Trans R Soc Trop Med Hyg 82: 221.
49. Su, X.Z., Carucci, D.J., and Wellems, T.E. (1998) Plasmodium falciparum: parasite typing by using a multicopy microsatellite marker, PfRRM. Exp Parasitol 89: 262-265.
50. Sullivan, D.J., Jr, Gluzman, I.Y., Russell, D.G., and Goldberg, D.E. (1996) On the molecular mechanism of chloroquine's antimalarial action. Proc Natl Acad Sci USA 93: 11865-11870.
51. Tallarida, R.J. (2001) Drug synergism: its detection and applications. J Pharmacol Exp Ther 298: 865-872.
52. Tran, C.V., and Saier, M.H., Jr (2004) The principal chloroquine resistance protein of Plasmodium falciparum is a member of the drug/metabolite transporter superfamily. Microbiology 150: 1-3.
53. Triggle, D.J. (1996) Ion channels as pharmacologic receptors: the chirality of drug interactions. Chirality 8: 35-38.
54. Vieira, P.P., Ferreira, M.U., Das Gracas Alecrim, M., Alecrim, W.D., Da Silva, L.H., Sihuincha, M.M., et al. (2004) pfcrt polymorphism and the spread of chloroquine resistance in Plasmodium falciparum populations across the Amazon Basin. J Infect Dis 190: 417-424.
55. Warhurst, D.C. (2003) Polymorphism in the Plasmodium falciparum chloroquine-resistance transporter protein links verapamil enhancement of chloroquine sensitivity with the clinical efficacy of amodiaquine. Malar J 2: 31.
56. Warhurst, D.C., Craig, J.C., and Adagu, I.S. (2002) Lysosomes and drug resistance in malaria. Lancet 360: 1527-1529.
57. Wesche, D.L., and Black, J. (1990) A comparison of the antimalarial activity of the cinchona alkaloids against Plasmodium falciparum in vitro. J Trop Med Hyg 93: 153-159.
58. Wigler, P.W., and Patterson, F.K. (1994) Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts. Biochim Biophys Acta 1189: 1-6.
59. Wootton, J.C., Feng, X., Ferdig, M.T., Cooper, R.A., Mu, J., Baruch, D.I., et al. (2002) Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418: 320-323.
60. Yayon, A., Cabantchik, Z.I., and Ginsburg, H. (1985) Susceptibility of human malaria parasites to chloroquine is pH dependent. Proc Natl Acad Sci USA 82: 2784-2788.
61. Zamyatnin, A.A. (1972) Protein volume in solution. Prog Biophys Mol Biol 24: 107-123.
62. Zhang, H., Paguio, M., and Roepe, P.D. (2004) The antimalarial drug resistance protein Plasmodium falciparum chloroquine resistance transporter binds chloroquine. Biochemistry 43: 8290-8296.